Maosheng Fang
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Effects of aripiprazole on prolactin levels and differences in effectiveness in patients with schizophrenia: a post-hoc analysis of the real-world data of a multicenter study.
Journal: Frontiers in psychiatry
Published: February 07, 2024
Aripiprazole in the treatment of acute episode of schizophrenia: a real-world study in China.
Journal: Chinese medical journal
Published: April 04, 2023
A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults.
Journal: Therapeutic advances in psychopharmacology
Published: February 02, 2023
Identifying the Subtypes of Major Depressive Disorder Based on Somatic Symptoms: A Longitudinal Study Using Latent Profile Analysis.
Journal: Frontiers in psychiatry
Published: August 16, 2021
Predictors and moderators of quality of life in patients with major depressive disorder: An AGTs-MDD study report.
Journal: Journal of psychiatric research
Published: February 19, 2021
Effects of CYP2D6, CYP3A5, and ABCB1 gene polymorphisms on the pharmacokinetics of two risperidone long-acting injection microsphere formulations.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: August 14, 2020
Insulin Resistance-Related Proteins Are Overexpressed in Patients and Rats Treated With Olanzapine and Are Reverted by Pueraria in the Rat Model.
Journal: Journal of clinical psychopharmacology
Published: April 05, 2019
Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance.
Journal: Scientific reports
Published: February 02, 2018
Olig2 Silence Ameliorates Cuprizone-Induced Schizophrenia-Like Symptoms in Mice.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: October 10, 2017
Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population.
Journal: Neuropsychiatric disease and treatment
Published: March 04, 2017
Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorder.
Journal: Scientific reports
Published: September 21, 2016
Last Updated: 09/26/2026